Literature DB >> 25414415

Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.

Richard A Cone1.   

Abstract

Vaginal microbiota and sexually transmitted infections (STIs) are likely to influence the transmission of cell-associated human immunodeficiency virus (HIV). Lactic acid produced by Lactobacillus-dominated microbiota (Nugent score 0-3) will likely inhibit transmission, especially female-to-male transmission. In contrast, polymicrobial microbiota (Nugent score 4-10), community state types IV-A and IV-B, and STIs will likely increase transmission of cell-associated HIV.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cell-associated HIV; inflammatory cytokines; lactic acid; polymicrobial microbiota

Mesh：

Substances：

Year:  2014        PMID： 25414415      PMCID： PMC4303075          DOI： 10.1093/infdis/jiu459

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  57 in total

Review 1.  Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis.

Authors:  V Pybus; A B Onderdonk
Journal:  Microbes Infect       Date:  1999-04       Impact factor: 2.700

Review 2.  The barrier to HIV transmission provided by genital tract Lactobacillus colonization.

Authors:  Paria Mirmonsef; Gregory T Spear
Journal:  Am J Reprod Immunol       Date:  2014-03-24       Impact factor: 3.886

3.  Autoradiographic analysis of cell proliferation kinetics in human genital tissues. I. Normal cervix and vagina.

Authors:  H E Averette; G D Weinstein; P Frost
Journal:  Am J Obstet Gynecol       Date:  1970-09-01       Impact factor: 8.661

4.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants.

Authors:  Y L Song; N Kato; Y Matsumiya; C X Liu; H Kato; K Watanabe
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle.

Authors:  D L Patton; S S Thwin; A Meier; T M Hooton; A E Stapleton; D A Eschenbach
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

8.  Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women.

Authors:  Janneke H H M van de Wijgert; Charles S Morrison; Peter G A Cornelisse; Marshall Munjoma; Jeanne Moncada; Peter Awio; Jing Wang; Barbara Van der Pol; Tsungai Chipato; Robert A Salata; Nancy S Padian
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

9.  Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data.

Authors:  Jenifer E Allsworth; Vanessa A Lewis; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2008-09       Impact factor: 2.830

10.  Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus.

Authors:  Gregory T Spear; Audrey L French; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Thomas H Sullivan; William W Spear; Alan Landay; Sandra Micci; Byung-Hoo Lee; Bruce R Hamaker
Journal:  J Infect Dis       Date:  2014-04-15       Impact factor: 5.226
View more
  24 in total

Review 1.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

2.  Effects of intrauterine contraception on the vaginal microbiota.

Authors:  Christine M Bassis; Jenifer E Allsworth; Heather N Wahl; Daniel E Sack; Vincent B Young; Jason D Bell
Journal:  Contraception       Date:  2017-06-15       Impact factor: 3.375

3.  Cell-associated HIV mucosal transmission: the neglected pathway.

Authors:  Deborah J Anderson; Roger Le Grand
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

Review 4.  Modeling mucosal cell-associated HIV type 1 transmission in vitro.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

5.  Use of a risk quiz to predict infection for sexually transmitted infections: a retrospective analysis of acceptability and positivity.

Authors:  Charlotte A Gaydos; Mary Jett-Goheen; Mathilda Barnes; Laura Dize; Perry Barnes; Yu-Hsiang Hsieh
Journal:  Sex Transm Infect       Date:  2015-08-18       Impact factor: 3.519

6.  Systemic Immune Activation and HIV Shedding in the Female Genital Tract.

Authors:  LaShonda Y Spencer; Shawna Christiansen; Chia-Hao H Wang; Wendy J Mack; Mary Young; Howard D Strickler; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Ruth M Geenblatt; Roksana Karim; Eva Operskalski; Toni Frederick; James D Homans; Alan Landay; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

Review 7.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

8.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020

9.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

10.  Genital Abnormalities, Hormonal Contraception, and Human Immunodeficiency Virus Transmission Risk in Rwandan Serodifferent Couples.

Authors:  Kristin M Wall; Etienne Karita; Julien Nyombayire; Rosine Ingabire; Jeannine Mukamuyango; Rachel Parker; Ilene Brill; Matt Price; Lisa B Haddad; Amanda Tichacek; Eric Hunter; Susan Allen
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 7.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.